secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001493152-23-033131
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma updates corporate presentation for investor meetings
----------------------------------------------------------------------

- Corporate presentation updated as of September 20, 2023 for use at conferences.
- No specific financial or operational details disclosed in the filing body.
- Investors should review the exhibit for any changes to strategy or pipeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315223033131/0001493152-23-033131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315223033131/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-033131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer